-
Diagnostics World News I New diagnostic assay allows testing and genomic surveillance simultaneously, a portable and bifunctional electrical detector for SARS-CoV-2, 1 in 3 infected asymptomatic. Plus: Melatonin produced in lungs could be used as a prognostic biomarker and machine learning predicts COVID-19 patient outcomes.
Jan 29, 2021
-
Diagnostics World News | Saliva for early lunch cancer detection, new guidelines for diagnosis of bleeding disorder, Babson claims fingerstick diagnostics in a retail setting, and looking at Alzheimer’s. Plus: companion diagnostic agreements, and genomic sequencing for prenatal testing.
Jan 28, 2021
-
Diagnostics World News | Moffitt Cancer Center researchers have discovered a way to pinpoint a subset of prostate cancer patients with aggressive tumors who may benefit from combined immune-radiotherapy modalities. The answer gets computed from a combination of the immune content score (ICS) and the 22-gene Decipher classifier score that is predictive of metastasis.
Jan 25, 2021
-
Diagnostics World News | Quantified smell loss the best predictor of COVID-19 among those with symptoms, the outlook for self-tests, circulating mitochondria as a warning of severe disease, and more. Plus: QIAGEN’s PCR test stands up to new variants, new development on tests to distinguish between SARS-CoV-2 and influenza.
Jan 22, 2021
-
Diagnostics World News | Cancer tries its hardest not to be found. Seeking to better understand the early tumor micro-environment may prove to be a powerful harbinger of early cancer development. In our quest for early cancer detection, we should look more closely at the complex and potentially detectable changes in the micro-environment surrounding the tumor.
Jan 19, 2021
-
Diagnostics World News I Princeton University spin-off launches AI COVID screening tool, new antibody test helps select donor blood samples for therapeutic use, concerns raised over UK’s rollout of rapid asymptomatic testing, and Wuhan study finds symptoms linger for many. Plus: FDA grants EUA for high-volume antigen test and asymptomatic testing, new simplified COVID-19 testing method, and nanomaterial-based biosensing platform detects COVID-19 antibodies in seconds.
Jan 15, 2021
-
Diagnostics World News | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, focusing heavily on a rosy outlook for clinical genomics.
Jan 12, 2021